Remedium Lifecare Fair Value
Remedium Lifecare (REMLIFE) average fair value is ₹9.96 across 5 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, vs a current market price of ₹0.87 (+1044.37%), fair value range ₹2.42–₹27.55. Examine REMLIFE quarterly results for recent quarterly revenue, profit and EPS trends.
Fair Value Analysis Export
REMLIFE Fair Value vs Current Price — Valuation Summary
REMLIFE average fair value, fair value range, price gap and valuation status across 5 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number. See REMLIFE P/B ratio history to compare market price against book value per share.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
REMLIFE Fair Value Analysis — Data Sources & Coverage
Remedium Lifecare financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. For live price and a broader fundamental view, visit REMLIFE share price.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
REMLIFE vs Commercial Services Sector Peers — P/E, P/B & Market Cap
Remedium Lifecare P/E ratio, P/B ratio and market capitalisation vs Commercial Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Quasar | QUASAR | - | 0.14 | ₹14 |
| Viksit Engineering | VIKSHEN | - | - | - |
| Sarthak Global | SARTHAKGL | 22.19 | 5.34 | ₹11 |
| Maximus International | MAXIMUS | 14.93 | 1.72 | ₹136 |
| Real Growth Corporation | RGCORP | - | - | - |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.